{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:49:04Z","timestamp":1780440544417,"version":"3.54.1"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.5414\/cp204053","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T09:41:27Z","timestamp":1633686087000},"page":"97-105","source":"Crossref","is-referenced-by-count":9,"title":["Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A\u00a0Bayesian network meta-analysis of randomized co"],"prefix":"10.5414","volume":"60","author":[{"given":"Young Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwan Gyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T12:27:45Z","timestamp":1643286465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=188837&doi=10.5414\/CP204053&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":0,"journal-issue":{"issue":"02","published-print":{"date-parts":[[2022]]}},"alternative-id":["204053"],"URL":"https:\/\/doi.org\/10.5414\/cp204053","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}